CD177 and cancer: GPCRs are known to be the largest family of cell surface receptors that regulate different biological responses and, therefore, are frequently used as drug targets for several diseases, including hypertension and cancer therapy (Brinks and Eckhart, 2010; Liu et al., 2016).